Longevity Estimator Software Error for Subset of Medtronic CIEDs
October 8, 2019 - On October 3, 2019, Medtronic began notifying healthcare professionals that a subset of pacemakers and implantable cardioverter defibrillators (including CRT and
Public comment promotes greater transparency in the clinical practice document development process and provides an opportunity for key stakeholders to critically review and offer feedback on draft recommendations prior to a clinical document’s finalization and publication.
Antiarrhythmic Drugs—Clinical Use and Clinical Decision Making: A Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology
HRS Comments- AHRQ Report on the Use of CRT (March 2019)
On March, 4 2019, the Heart Rhythm Society (HRS) submitted comments to the Agency for Healthcare Research and Quality’s (AHRQ) in response to the Agency's Technology Assessm
2012 EHRA/HRS Expert Consensus Statement on Cardiac Resynchronization Therapy in Heart Failure: Implant and Follow-up Recommendations and Management
September 1, 2012—The expert consensus statement provides recommendations for the practical management of cardiac resynchronization therapy (CRT) patients before, during,
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
September 10, 2012—The statement provides expanded indications for cardiac resynchronization therapy (CRT) in an effort to clarify which patients are most likely to benefit from CRT. Addi